1. Home
  2. BLBX vs RNTX Comparison

BLBX vs RNTX Comparison

Compare BLBX & RNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLBX
  • RNTX
  • Stock Information
  • Founded
  • BLBX 2014
  • RNTX 2001
  • Country
  • BLBX United States
  • RNTX United States
  • Employees
  • BLBX N/A
  • RNTX N/A
  • Industry
  • BLBX EDP Services
  • RNTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • BLBX Technology
  • RNTX Health Care
  • Exchange
  • BLBX Nasdaq
  • RNTX Nasdaq
  • Market Cap
  • BLBX 23.9M
  • RNTX 26.5M
  • IPO Year
  • BLBX N/A
  • RNTX N/A
  • Fundamental
  • Price
  • BLBX $6.25
  • RNTX $1.35
  • Analyst Decision
  • BLBX
  • RNTX Hold
  • Analyst Count
  • BLBX 0
  • RNTX 1
  • Target Price
  • BLBX N/A
  • RNTX N/A
  • AVG Volume (30 Days)
  • BLBX 46.2K
  • RNTX 65.2K
  • Earning Date
  • BLBX 08-14-2025
  • RNTX 08-14-2025
  • Dividend Yield
  • BLBX N/A
  • RNTX N/A
  • EPS Growth
  • BLBX N/A
  • RNTX N/A
  • EPS
  • BLBX N/A
  • RNTX N/A
  • Revenue
  • BLBX $2,338,675.00
  • RNTX N/A
  • Revenue This Year
  • BLBX N/A
  • RNTX N/A
  • Revenue Next Year
  • BLBX N/A
  • RNTX N/A
  • P/E Ratio
  • BLBX N/A
  • RNTX N/A
  • Revenue Growth
  • BLBX N/A
  • RNTX N/A
  • 52 Week Low
  • BLBX $1.51
  • RNTX $1.04
  • 52 Week High
  • BLBX $9.50
  • RNTX $4.40
  • Technical
  • Relative Strength Index (RSI)
  • BLBX 46.03
  • RNTX 56.38
  • Support Level
  • BLBX $5.64
  • RNTX $1.06
  • Resistance Level
  • BLBX $6.79
  • RNTX $1.40
  • Average True Range (ATR)
  • BLBX 0.49
  • RNTX 0.12
  • MACD
  • BLBX -0.05
  • RNTX 0.03
  • Stochastic Oscillator
  • BLBX 40.00
  • RNTX 85.29

About BLBX Blackboxstocks Inc.

Blackboxstocks Inc is a financial technology and social media hybrid platform offering real-time proprietary analytics and news for stock and options traders of all levels. Its web-based software (the Blackbox System) employs predictive technology enhanced by artificial intelligence to find volatility and unusual market activity that may result in a rapid change in the price of a stock or option. It provides users with a fully interactive social media platform that is integrated into its dashboard, enabling users to exchange information and ideas quickly and efficiently through a common network. The company introduced a live audio/video feature that allows members to broadcast on their channels to share trading strategies and market insight within the Blackbox community.

About RNTX Rein Therapeutics Inc. Common Stock

Rein Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing therapies in orphan pulmonary and fibrosis indications, including two Phase 2-ready clinical assets. The company's product candidate includes LTI-03: a peptide for which company conducted a Phase 1b dose-ranging, placebo-controlled safety, tolerability, and pharmacodynamic biomarker activity trial in development for the treatment of Idiopathic Pulmonary Fibrosis; LTI-01: proenzyme that completed a Phase 2a dose-ranging, placebo-controlled trial and a Phase 1b safety, tolerability and proof of mechanism trial in loculated pleural effusion, or LPE, patients, an indication that has no approved drug treatment; and LTI-05 and others.

Share on Social Networks: